Published

AVS enrols first patient in US pivotal intravascular lithotripsy study - Interventional News

Summary by Interventional News
Pulse console Amplitude Vascular Systems (AVS) recently announced that it has enrolled the first patient in its US pivotal trial for pulsatile intravascular lithotripsy (IVL) therapy. A press release notes that the POWER PAD II clinical study will evaluate the safety and efficacy of AVS’s Pulse IVL system for the treatment of patients with moderate to severely calcified peripheral arterial disease (PAD). Nicolas W Shammas conducted the first ca…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.